# Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients

> **NCT06481813** · NA · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 730 (estimated)

## Conditions studied

- Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Small Cell Lung Carcinoma
- Metastatic Lung Cancer

## Interventions

- **OTHER:** Blood Sampling (2*8mL Tubes)
- **OTHER:** PBMC Sampling (1*8mL Tubes)
- **OTHER:** Paxgene Sampling
- **PROCEDURE:** Extended biopsies of tumor lesions

## Key facts

- **NCT ID:** NCT06481813
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2029-12-01
- **Final completion:** 2034-12-01
- **Target enrollment:** 730 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481813, "Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06481813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*